In liver cancer cells, TGF-β1 can regulate CD133 expression through the inhibition of DNMT1 and DNMT3b expressions; TGF-β1 stimulation results in a significant demethylation of CD133 promoter-1 [41]. Here, PROM1 is linked to liver cancer.